CTC
GILD icon

Corundum Trust Company’s Gilead Sciences GILD Stock Holding History

Corundum Trust Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-234
Closed -$26K – 76
2025
Q3 		$26K Buy
+234
New +$26.6K 0.06% 96

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Corundum Trust Company's GILD Position: Q4 2025 in Review

Corundum Trust Company sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 234 shares — an estimated $26K sold.

Corundum Trust Company first reported a position in GILD in Q3 2025 and held it in 1 quarter. The position peaked at $26K in Q3 2025. 2,228 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Corundum Trust Company reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Corundum Trust Company sold 234 Gilead Sciences shares in Q4 2025, an estimated $26K.
  • Corundum Trust Company first reported a position in Gilead Sciences in Q3 2025 and held it in 1 quarter.
  • Corundum Trust Company's Gilead Sciences position peaked at $26K in Q3 2025.
  • 2,228 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Corundum Trust Company's 13F filing for Q4 2025, filed 20 Jan 2026.